Nexgel (NXGL) Return on Sales (2018 - 2025)

Nexgel (NXGL) has 8 years of Return on Sales data on file, last reported at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales for Q4 2025 stood at 0.0%, down from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q3 2025 and bottomed at 0.05% in Q1 2022.
• The 5-year median for Return on Sales is 0.01% (2024), against an average of 0.01%.
• The widest annual swing landed in 2021, when Return on Sales increased 4 bps; it then fell 2 bps in 2022.
• A 5-year view of Return on Sales shows it stood at 0.03% in 2021, then jumped by 63 bps to 0.01% in 2022, then climbed by 11 bps to 0.01% in 2023, then jumped by 75 bps to 0.0% in 2024, then slipped by 22 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.

Peer Comparison